Inventor
THOMPSON ANDREW S
US34 patents
⚠️ This page may combine multiple inventors who share the name “THOMPSON ANDREW S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
15 patentsUS6369247B1Apr 9, 2002
Process for oxidation of steroidal compounds having allylic groups
MERCK & CO INC31 citations92
US5633405AMay 27, 1997
Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one
MERCK & CO INC21 citations92
US6939964B2Sep 6, 2005
Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
MERCK & CO INC15 citations90
US6639071B2Oct 28, 2003
Crystal Forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
MERCK & CO INC17 citations90
US5149838ASep 22, 1992
Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents
MERCK & CO INC33 citations89
US5663467ASep 2, 1997
Synthesis of cyclopropylacetylene
MERCK & CO INC18 citations79
US5698741ADec 16, 1997
Asymmetric synthesis of (-)6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
MERCK & CO INC5 citations74
US5391772AFeb 21, 1995
Converting an alcohol to an azide with SN 2 inversion using a phosphoryl azide
MERCK & CO INC9 citations74
US5508435AApr 16, 1996
Asymmetric hydrogenation of beta- or gamma-ketoesters and beta- or gamma-ketoamides
MERCK & CO INC14 citations70
US5264574ANov 23, 1993
Preparation of oxazaborolidine borane complex
MERCK & CO INC8 citations69
US5654424AAug 5, 1997
Preparation of beta-methyl carbapenem intermediates
MERCK & CO INC2 citations63
US4866186ASep 12, 1989
Process for the formation of 6-desmethyl-6-exo-methylene derivatives of lovastatin and analogs thereof
MERCK & CO INC4 citations63
US6242596B1Jun 5, 2001
Preparation of betamethyl carbapenem intermediates
MERCK & CO INC1 citations52
US5693812ADec 2, 1997
Polymorphic forms of an angiotensin II antagonist
MERCK & CO INC1 citations49
US5099033AMar 24, 1992
Process of making 2,5-diaryl tetrahydrofurans and analogs thereof useful as PAF antagonists
MERCK & CO INC0 citations42
INTRA CELLULAR THERAPIES INC
8 patentsUS9751883B2Sep 5, 2017
Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof
INTRA CELLULAR THERAPIES INC86 citations99
US9315504B2Apr 19, 2016
Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereof
INTRA CELLULAR THERAPIES INC88 citations99
US10464938B2Nov 5, 2019
Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof
INTRA CELLULAR THERAPIES INC33 citations98
US10221176B2Mar 5, 2019
Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof
INTRA CELLULAR THERAPIES INC28 citations98
US11407751B2Aug 9, 2022
Hydrochloric acid salt of (6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxaline
INTRA CELLULAR THERAPIES INC19 citations94
US11066407B2Jul 20, 2021
Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof
INTRA CELLULAR THERAPIES INC14 citations94
US10597395B2Mar 24, 2020
Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereof
INTRA CELLULAR THERAPIES INC23 citations94
US12139490B2Nov 12, 2024
Process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one
INTRA CELLULAR THERAPIES INC0 citations62